Clinical Research and Regulatory Support Core

临床研究和监管支持核心

基本信息

  • 批准号:
    10281549
  • 负责人:
  • 金额:
    $ 32.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

The proposed Clinical Research and Regulatory Support (CRRS) Core will play a vital role in enhancing the development of a robust clinical and translational (CTR) infrastructure for the Center for Pacific Innovations, Knowledge, and Opportunities (PIKO). The CRRS Core will provide Junior Investigators (JI), and Established Investigators (EI) transitioning to CTR across the CTR continuum, with the necessary clinical research expertise, resources, and facilities to conduct CTR aimed at improving the health of Indigenous Pacific People (IPP), defined as Native Hawaiians, Other Pacific Islanders, and Filipinos, and other medically underserved and vulnerable groups. The CRRS Core will also assist JI/EI in navigating the daunting process of ensuring that their proposed research is ethical and addresses all human subject and regulatory concerns. The CRRS Core will promote harmonization of institutional review board procedures throughout community and partner institutions, participate in mentoring activities organized by the Professional Development (PD) Core, collaborate with the Biostatistics, Epidemiology, and Research Design (BERD) Core in developing case report forms and inputting data into the study database, and work with the Community Engagement and Outreach (CEO) Core to share information with health care professionals and community leaders. This Core’s Specific Aims are: Specific Aim 1: Mentor CTR investigators on the practical aspects of conducting high-quality CTR by assisting JI/EI with study feasibility and implementation issues; facilitating linkage to medical resources and advocate for transdisciplinary and team-science opportunities; providing regulatory mentoring support for CTR implementation; participating in PIKO-sponsored professional development activities. Specific Aim 2: Enable direct access to critical CTR implementation resources and facilities by providing CTR personnel resources (research nurse/associate and processing laboratory technician services); providing access to clinic facilities; enabling access to an independent Data Safety Monitoring Board and Ethics Board resources; advancing CTR technology and outreach to support T2–T5 clinical research. The CRRS Core will provide services at three clinical sites – John A. Burns School of Medicine (JABSOM), Queen’s Medical Center (QMC), and Kapiolani Medical Center for Women and Children (KMCWC). As CRRS Core Director, Cecilia M. Shikuma, MD, supported by Associate Core Directors Todd Seto, MD, and Bliss Kaneshiro, MD, will oversee the Core operations at JABSOM, QMC and KMCWC, respectively. Venkataraman Balaraman, MD, will oversee the ethics and regulatory services. The innovation of combining regulatory and ethics resources with CTR implementation services within a single core will allow the CRRS Core to offer integrated and personalized services to JI/EI engaging in CTR.
拟议的临床研究和监管支持(CRRS)核心将在加强 为太平洋创新中心开发强大的临床和转换(CTR)基础设施, 知识和机会(PIKO)。CRRS核心将提供初级调查员(JI),并建立 研究人员(EI)在整个CTR过程中过渡到CTR,拥有必要的临床研究专业知识, 开展旨在改善太平洋土著人民健康的CTR的资源和设施; 被定义为夏威夷原住民、其他太平洋岛民和菲律宾人,以及其他医疗服务不足和 弱势群体。CRRS核心还将协助联检组/EI驾驭这一艰巨的进程,以确保他们的 拟议的研究是符合道德的,并解决了所有人类主体和监管方面的问题。CRRS的核心将 促进整个社区和伙伴机构机构审查委员会程序的统一, 参与由专业发展(PD)核心组织的指导活动,与 生物统计学、流行病学和研究设计(BERD)在开发病例报告表和输入方面的核心 将数据输入研究数据库,并与社区参与和外联(CEO)核心合作共享 向卫生保健专业人员和社区领袖提供信息。这一核心的具体目标是: 具体目标1:指导CTR调查员进行高质量CTR的实际方面 协助联检组处理研究可行性和实施问题;促进与医疗资源的联系; 倡导跨学科和团队科学机会;为CTR提供监管指导支持 实施;参加PIKO赞助的职业发展活动。 具体目标2:通过以下方式实现对关键的CTR执行资源和设施的直接访问 提供CTR人员资源(研究护士/助理和加工实验室技术人员服务); 提供对诊所设施的访问;允许访问独立的数据安全监测委员会和道德规范 董事会资源;推进CTR技术和推广,以支持T2-T5临床研究。 CRRS核心将在三个临床地点提供服务-约翰·A·伯恩斯医学院(JABSOM), 女王医学中心(QMC)和卡皮奥拉尼妇女儿童医学中心(KMCWC)。作为CRR 核心董事,Cecilia M.Shikuma,MD,由副核心董事Todd Seto,MD和Bliss支持 Kaneshiro医学博士将分别负责JABSOM、QMC和KMCWC的核心业务。文卡塔拉曼 Balaraman医学博士将负责道德和监管服务。监管与监管相结合的创新 道德资源与单一核心内的CTR实施服务将使CRRS核心能够提供 向参与CTR的联检组/EI提供综合和个性化的服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cecilia M. Shikuma其他文献

S100B and its association with HIV-associated neurocognitive disorders
  • DOI:
    10.1007/s13365-019-00773-8
  • 发表时间:
    2019-07-05
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Nath Limpruttidham;Brooks I. Mitchell;Kalpana J. Kallianpur;Beau K. Nakamoto;Scott A. Souza;Bruce Shiramizu;Lishomwa C. Ndhlovu;Dominic C. Chow;Cecilia M. Shikuma
  • 通讯作者:
    Cecilia M. Shikuma

Cecilia M. Shikuma的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cecilia M. Shikuma', 18)}}的其他基金

Clinical Research and Regulatory Support Core
临床研究和监管支持核心
  • 批准号:
    10474450
  • 财政年份:
    2021
  • 资助金额:
    $ 32.28万
  • 项目类别:
Clinical Research and Regulatory Support Core
临床研究和监管支持核心
  • 批准号:
    10685401
  • 财政年份:
    2021
  • 资助金额:
    $ 32.28万
  • 项目类别:
Maraviroc and NeuroAIDS Pathogenesis
马拉韦罗和神经艾滋病发病机制
  • 批准号:
    8667965
  • 财政年份:
    2014
  • 资助金额:
    $ 32.28万
  • 项目类别:
Maraviroc and NeuroAIDS Pathogenesis
马拉韦罗和神经艾滋病发病机制
  • 批准号:
    9266148
  • 财政年份:
    2014
  • 资助金额:
    $ 32.28万
  • 项目类别:
Maraviroc and NeuroAIDS Pathogenesis
马拉韦罗和神经艾滋病发病机制
  • 批准号:
    9096234
  • 财政年份:
    2014
  • 资助金额:
    $ 32.28万
  • 项目类别:
Clinical Studies
临床研究
  • 批准号:
    8061611
  • 财政年份:
    2010
  • 资助金额:
    $ 32.28万
  • 项目类别:
HIV RESEARCH CORE
艾滋病毒研究核心
  • 批准号:
    7960428
  • 财政年份:
    2009
  • 资助金额:
    $ 32.28万
  • 项目类别:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
HIV 和全球药物治疗:周围神经病变并发症和机制
  • 批准号:
    8112457
  • 财政年份:
    2008
  • 资助金额:
    $ 32.28万
  • 项目类别:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
HIV 和全球药物治疗:周围神经病变并发症和机制
  • 批准号:
    8133664
  • 财政年份:
    2008
  • 资助金额:
    $ 32.28万
  • 项目类别:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
氧化应激和炎症在艾滋病毒心血管风险中的作用
  • 批准号:
    7691231
  • 财政年份:
    2008
  • 资助金额:
    $ 32.28万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 32.28万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 32.28万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 32.28万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 32.28万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 32.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了